Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-027662

Options or other derivatives

  • Director acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kunkel Lori Anne · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-05 Grant or award : show line 1 in the form Director Stock Option (right to buy) +17,500 17,500 D
Loading xslF345X03/doc4.xml…